{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T15:54:32Z","timestamp":1776268472642,"version":"3.50.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"S6","license":[{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T00:00:00Z","timestamp":1664496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG072799"],"award-info":[{"award-number":["RF1AG072799"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01AT009457"],"award-info":[{"award-number":["R01AT009457"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI130460"],"award-info":[{"award-number":["R01AI130460"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To date, there are no effective treatments for most neurodegenerative diseases. Knowledge graphs can provide comprehensive and semantic representation for heterogeneous data, and have been successfully leveraged in many biomedical applications including drug repurposing. Our objective is to construct a knowledge graph from literature to study the relations between Alzheimer\u2019s disease (AD) and chemicals, drugs and dietary supplements in order to identify opportunities to prevent or delay neurodegenerative progression. We collected biomedical annotations and extracted their relations using SemRep via SemMedDB. We used both a BERT-based classifier and rule-based methods during data preprocessing to exclude noise while preserving most AD-related semantic triples. The 1,672,110 filtered triples were used to train with knowledge graph completion algorithms (i.e., TransE, DistMult, and ComplEx) to predict candidates that might be helpful for AD treatment or prevention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among three knowledge graph completion models, TransE outperformed the other two (MR = 10.53, Hits@1 = 0.28). We leveraged the time-slicing technique to further evaluate the prediction results. We found supporting evidence for most highly ranked candidates predicted by our model which indicates that our approach can inform reliable new knowledge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This paper shows that our graph mining model can predict reliable new relationships between AD and other entities (i.e., dietary supplements, chemicals, and drugs). The knowledge graph constructed can facilitate data-driven knowledge discoveries and the generation of novel hypotheses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12859-022-04934-1","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T09:12:00Z","timestamp":1664529120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Mining on Alzheimer\u2019s diseases related knowledge graph to identity potential AD-related semantic triples for drug repurposing"],"prefix":"10.1186","volume":"23","author":[{"given":"Yi","family":"Nian","sequence":"first","affiliation":[]},{"given":"Xinyue","family":"Hu","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Jingna","family":"Feng","sequence":"additional","affiliation":[]},{"given":"Jingcheng","family":"Du","sequence":"additional","affiliation":[]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[]},{"given":"Larry","family":"Bu","sequence":"additional","affiliation":[]},{"given":"Yuji","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-1924","authenticated-orcid":false,"given":"Cui","family":"Tao","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,9,30]]},"reference":[{"key":"4934_CR1","unstructured":"Neurodegenerative diseases latest research and news. https:\/\/www.nature.com\/subjects\/neurodegenerative-diseases. Accessed 01 Oct 2022."},{"issue":"2","key":"4934_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1074\/mcp.R115.053330","volume":"15","author":"G Moya-Alvarado","year":"2016","unstructured":"Moya-Alvarado G, Gershoni-Emek N, Perlson E, Bronfman F. Neurodegeneration and Alzheimer\u2019s disease (ad). What can proteomics tell us about the Alzheimer\u2019s brain? Mol Cell Proteom. 2016;15(2):409\u201325.","journal-title":"Mol Cell Proteom"},{"issue":"3","key":"4934_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/jamia\/ocz199","volume":"27","author":"R Duan","year":"2020","unstructured":"Duan R, Boland M, Liu Z, Liu Y, Chang H, Xu H, Chu H, Schmid C, Forrest C, Holmes J, Schuemie M, Berlin J, Moore J, Chen Y. Learning from electronic health records across multiple sites: a communication-efficient and privacy-preserving distributed algorithm. J Am Med Inf Assoc. 2020;27(3):376\u201385.","journal-title":"J Am Med Inf Assoc"},{"key":"4934_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"T Ashburn","year":"2004","unstructured":"Ashburn T, Thor K. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3:673\u201383.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"4934_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","volume":"27","author":"P Kyungsoo","year":"2019","unstructured":"Kyungsoo P. A review of computational drug repurposing. Trans Clin Pharmacol. 2019;27(2):59\u201363. https:\/\/doi.org\/10.12793\/tcp.2019.27.2.59.","journal-title":"Trans Clin Pharmacol"},{"issue":"1","key":"4934_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers P, Escott K, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41\u201358.","journal-title":"Nat Rev Drug Discov"},{"key":"4934_CR7","doi-asserted-by":"crossref","unstructured":"Bonner S, Barrett I, Ye C, Swiers R, Engkvist O, Bender A, Hoyt C, Hamilton W. A review of biomedical datasets relating to drug discovery: a knowledge graph perspective. arXiv preprint arXiv:2102.10062 (2021)","DOI":"10.1093\/bib\/bbac404"},{"key":"4934_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2021.103696","volume":"115","author":"R Zhang","year":"2021","unstructured":"Zhang R, Hristovski D, Schutte D, Kastrin A, Fiszman M, Kilicoglu H. Drug repurposing for COVID-19 via knowledge graph completion. J Biomed Inf. 2021;115: 103696.","journal-title":"J Biomed Inf"},{"key":"4934_CR9","doi-asserted-by":"crossref","unstructured":"Yan V, Li X, Ye X, Ou M, Luo R, Zhang Q, Tang B, BJ C, I H, Siu C, ICK W, RCK C, EW C. Drug repurposing for the treatment of COVID-19: a knowledge graph approach. Adv Ther (Weinh). 2021;4(10):2100179.","DOI":"10.1002\/adtp.202100179"},{"issue":"8","key":"4934_CR10","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1021\/acs.jcim.1c00642","volume":"61","author":"J Al-Saleem","year":"2021","unstructured":"Al-Saleem J, Granet R, Ramakrishnan S, Ciancetta N, Saveson C, Gessner C, Zhou Q. Knowledge graph-based approaches to drug repurposing for COVID-19. J Chem Inf Model. 2021;61(8):4058\u201367. https:\/\/doi.org\/10.1021\/acs.jcim.1c00642 (PMID: 34297570).","journal-title":"J Chem Inf Model"},{"key":"4934_CR11","doi-asserted-by":"crossref","unstructured":"Sosa, D, Derry A, Guo M, Wei E, Brinton C, Altman R. A literature-based knowledge graph embedding method for identifying drug repurposing opportunities in rare diseases. Pac Symp Biocomput 2020; 25","DOI":"10.1101\/727925"},{"key":"4934_CR12","doi-asserted-by":"crossref","unstructured":"Malas T, Vlietstra W, Kudrin R, Starikov S, Charrout M, Roos M, Peters D, Kors J, Vos R, PAC H, Mulligen E, Hettne K. Drug prioritization using the semantic properties of a knowledge graph. Sci Rep. 2019;9(1):6281.","DOI":"10.1038\/s41598-019-42806-6"},{"key":"4934_CR13","doi-asserted-by":"publisher","first-page":"12795","DOI":"10.1523\/JNEUROSCI.3520-09.2009","volume":"29","author":"J Joseph","year":"2009","unstructured":"Joseph J, Cole G, Head E, Ingram D. Nutrition, brain aging, and neurodegeneration. J Neurosci. 2009;29:12795\u2013801.","journal-title":"J Neurosci"},{"key":"4934_CR14","unstructured":"PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/. Accessed 2022."},{"issue":"4","key":"4934_CR15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jamia\/ocz216","volume":"27","author":"R Rizvi","year":"2020","unstructured":"Rizvi R, Vasilakes J, Adam T, Melton G, Bishop J, Bian J, Tao C, Zhang R. iDISK: the integrated DIetary supplements knowledge base. J Am Med Inf Assoc. 2020;27(4):539\u201348.","journal-title":"J Am Med Inf Assoc"},{"key":"4934_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2147\/NDT.S3685","volume":"45","author":"JM Alisky","year":"2008","unstructured":"Alisky JM. Intrathecal corticosteroids might slow Alzheimer\u2019s disease progression. Neuropsychiatr Dis treat. 2008;45:831.","journal-title":"Neuropsychiatr Dis treat"},{"issue":"2","key":"4934_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032112","volume":"10","author":"D Devanand","year":"2020","unstructured":"Devanand D, Andrews H, Kreisl W, Razlighi Q, Gershon A, Stern Y, Mintz A, Wisniewski T, Acosta E, Pollina J, Katsikoumbas M, Bell K, Pelton G, Deliyannides D, Prasad K, Huey E. Antiviral therapy: valacyclovir treatment of Alzheimer\u2019s disease (valad) trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial. BMJ Open. 2020;10(2): e0321112.","journal-title":"BMJ Open"},{"key":"4934_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-64797-5","volume":"10","author":"H Dodiya","year":"2020","unstructured":"Dodiya H, Frith M, Sidebottom A, Cao Y, Koval J, Chang E, Sisodia S. Synergistic depletion of gut microbial consortia, but not individual antibiotics, reduces amyloidosis in appps1-21 Alzheimer\u2019s transgenic mice. Sci Rep. 2020;10:1\u201310.","journal-title":"Sci Rep"},{"key":"4934_CR19","unstructured":"A pilot open labeled study of tacrolimus in Alzheimer\u2019s disease. https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT04263519. Accessed 2022."},{"issue":"5","key":"4934_CR20","doi-asserted-by":"publisher","first-page":"831","DOI":"10.2147\/NDT.S3685","volume":"4","author":"J Alisky","year":"2008","unstructured":"Alisky J. Intrathecal corticosteroids might slow Alzheimer\u2019s disease progression. Neuropsychiatr Dis Treat. 2008;4(5):831.","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"4934_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2174\/1570159X15666170116143743","volume":"15","author":"R Ricciarelli","year":"2017","unstructured":"Ricciarelli R, Fedele E. The amyloid cascade hypothesis in Alzheimer\u2019s disease: it\u2019s time to change our mind. Curr Neuropharmacol. 2017;15(6):926\u201335.","journal-title":"Curr Neuropharmacol"},{"issue":"10","key":"4934_CR22","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1017\/S1461145713000631","volume":"16","author":"M Dobarro","year":"2013","unstructured":"Dobarro M, Gerenu G, Ram\u00edrez M. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer\u2019s transgenic mice. Int J Neuropsychopharmacol. 2013;16(10):2245\u201357.","journal-title":"Int J Neuropsychopharmacol"},{"key":"4934_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.770502","author":"S Boutros","year":"2021","unstructured":"Boutros S, Zimmerman B, Nagy S, Lee J, Perez R, Raber J. Amifostine (wr-2721) mitigates cognitive injury induced by heavy ion radiation in male mice and alters behavior and brain connectivity. Front Physiol. 2021. https:\/\/doi.org\/10.3389\/fphys.2021.770502.","journal-title":"Front Physiol"},{"key":"4934_CR24","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/jnc.12094","volume":"3","author":"G-S Chai","year":"2013","unstructured":"Chai G-S, Jiang X, Ni Z-F, Ma Z-W, Xie A-J, Cheng X-S, Wang Q, Wang J-Z, Liu G-P. Betaine attenuates Alzheimer-like pathological changes and memory deficits induced by homocysteine. J Neurochem. 2013;3:388\u201396.","journal-title":"J Neurochem"},{"issue":"6","key":"4934_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1212\/WNL.37.6.1001","volume":"37","author":"M Mazurek","year":"1987","unstructured":"Mazurek M, Beal M, Bird E, Martin J. Oxytocin in Alzheimer\u2019s disease: postmortem brain levels. Neurology. 1987;37(6):1001\u20131001.","journal-title":"Neurology"},{"key":"4934_CR26","doi-asserted-by":"crossref","unstructured":"Sureda A, Daglia M, Castilla S, Sanadgol N, Nabavi S, Khan H, Belwal T, Jeandet P, Marchese A, Pistollato F, Forbes-Hernandez T, Battino M, Berindan-Neagoe I, G D, Nabavi S. Oral microbiota and Alzheimer\u2019s disease: Do all roads lead to rome?. Pharmacol Res. 2020;151:104582.","DOI":"10.1016\/j.phrs.2019.104582"},{"issue":"5","key":"4934_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1515\/revneuro-2013-0040","volume":"24","author":"C Li","year":"2013","unstructured":"Li C, Yuan K, Schluesener H. Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis. Rev Neurosci. 2013;24(5):553\u201362.","journal-title":"Rev Neurosci"},{"issue":"10","key":"4934_CR28","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00702-018-1913-1","volume":"125","author":"M Bortolanza","year":"2018","unstructured":"Bortolanza M, Nascimento G, Socias S, Ploper D, Cheh\u00edn R, Raisman-Vozari R, Del-Bel E. Tetracycline repurposing in neurodegeneration: focus on Parkinson\u2019s disease. J Neural Transm (Vienna). 2018;125(10):1403\u201315.","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"4934_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1515\/jbcpp-2014-0117","volume":"26","author":"V Verma","year":"2015","unstructured":"Verma V, Bali A, Singh N, Jaggi A. Implications of sodium hydrogen exchangers in various brain diseases. J Basic Clin Physiol Pharmacol. 2015;26(5):417\u201326.","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"4934_CR30","unstructured":"A study to determine the clinical safety\/tolerability and exploratory efficacy of EHT 0202 as adjunctive therapy to acetylcholinesterase inhibitor in mild to moderate Alzheimer\u2019s disease (EHT0202\/002). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00880412. Accessed 2022."},{"issue":"6","key":"4934_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100395","volume":"9","author":"T Fujimaki","year":"2014","unstructured":"Fujimaki T, Saiki S, Tashiro E, Yamada D, Kitagawa M, Hattori N, Imoto M. Identification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for parkinson\u2019s disease. PLoS One. 2014;9(6): e100395.","journal-title":"PLoS One"},{"key":"4934_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107758","volume":"160","author":"M Mei","year":"2019","unstructured":"Mei M, Zhou Y, Liu M, Zhao F, Wang C, Ding J, Lu M, Hu G. Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of parkinson\u2019s disease. Neuropharmacology. 2019;160: 107758. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107758.","journal-title":"Neuropharmacology"},{"key":"4934_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlw043","author":"B Owona","year":"2016","unstructured":"Owona B, Zug C, Schluesener H, Zhang Z. Protective effects of Forskolin on behavioral deficits and neuropathological changes in a mouse model of cerebral amyloidosis. J Neuropathol Exp Neurol. 2016. https:\/\/doi.org\/10.1093\/jnen\/nlw043.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"4934_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126880","volume":"30","author":"M Carreiras","year":"2020","unstructured":"Carreiras M, Ismaili L, Marco-Contelles J. Propargylamine-derived multi-target directed ligands for Alzheimer\u2019s disease therapy. Bioorg Med Chem Lett. 2020;30(3): 126880.","journal-title":"Bioorg Med Chem Lett"},{"key":"4934_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.neuropharm.2017.05.026","volume":"123","author":"T Amit","year":"2017","unstructured":"Amit T, Bar-Am O, Mechlovich D, Kupershmidt L, Youdim MOW. The novel multitarget iron chelating and propargylamine drug m30 affects app regulation and processing activities in Alzheimer\u2019s disease models. Neuropharmacology. 2017;123:359\u201367.","journal-title":"Neuropharmacology"},{"key":"4934_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.701899","author":"H Ou","year":"2021","unstructured":"Ou H, Chien W, Chung C, Chang H, Kao Y, Wu P, Tzeng N. Association between antibiotic treatment of chlamydia pneumoniae and reduced risk of Alzheimer dementia: a nationwide cohort study in taiwan. Front Aging Neurosci. 2021. https:\/\/doi.org\/10.3389\/fnagi.2021.701899.","journal-title":"Front Aging Neurosci"},{"key":"4934_CR37","doi-asserted-by":"crossref","unstructured":"Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer\u2019s disease. J Neuroinflammation. 2019; 16108","DOI":"10.1186\/s12974-019-1494-4"},{"key":"4934_CR38","first-page":"CD006378","volume":"2","author":"D Jaturapatporn","year":"2012","unstructured":"Jaturapatporn D, Isaac M, McCleery J, Tabet N. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2012;2:CD006378.","journal-title":"Cochrane Database Syst Rev"},{"key":"4934_CR39","first-page":"53","volume":"18","author":"D Lara","year":"2003","unstructured":"Lara D, Cruz MR, Xavier F, Souza D, Moriguchi E. Allopurinol for the treatment of aggressive behaviour in patients with dementia. Int Clin Psychopharmacol. 2003;18:53\u20135.","journal-title":"Int Clin Psychopharmacol"},{"key":"4934_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.736786","author":"MA Tikhonova","year":"2021","unstructured":"Tikhonova MA, Amstislavskaya TG, Ho Y, Akopyan AA, Tenditnik MV, Ovsyukova MV, Bashirzade AA, Dubrovina NI, Aftanas LI. Neuroprotective effects of ceftriaxone involve the reduction of a\u03b2 burden and neuroinflammatory response in a mouse model of Alzheimer\u2019s disease. Front Neurosci. 2021. https:\/\/doi.org\/10.3389\/fnins.2021.736786.","journal-title":"Front Neurosci"},{"issue":"4","key":"4934_CR41","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.3233\/JAD-170742","volume":"61","author":"W Fernando","year":"2018","unstructured":"Fernando W, Stephanie R, Gardener S, Villemagne V, Burnham S, Macaulay SL, Brown B, Gupta VB, Sohrabi H, Weinborn M, Taddei K, Laws S, Goozee K, Ames D, Fowler C, Maruff P, Masters C, Salvado O, Rowe C, Martins R. Associations of dietary protein and fiber intake with brain and blood amyloid-\u03b2. J Alzheimers Dis. 2018;61(4):1589\u201398.","journal-title":"J Alzheimers Dis"},{"key":"4934_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/nu11051165","author":"S Kakutani","year":"2019","unstructured":"Kakutani S, Watanabe H, Murayama N. Green tea intake and risks for dementia, Alzheimer\u2019s disease, mild cognitive impairment, and cognitive impairment: a systematic review. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11051165.","journal-title":"Nutrients"},{"issue":"1","key":"4934_CR43","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11130-019-00791-1","volume":"75","author":"E Baranowska-W\u00f3jcik","year":"2020","unstructured":"Baranowska-W\u00f3jcik E, Szwajgier D, Winiarska-Mieczan A. Honey as the potential natural source of cholinesterase inhibitors in Alzheimer\u2019s disease. Plant Foods Human Nutr. 2020;75(1):30\u20132.","journal-title":"Plant Foods Human Nutr"},{"key":"4934_CR44","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/ajcn\/nqz148","volume":"110","author":"M Ylilauri","year":"2019","unstructured":"Ylilauri M, Voutilainen S, Eija L, Virtanen HEK, Tuomainen T, Salonen J, Virtanen J. Associations of dietary choline intake with risk of incident dementia and with cognitive performance: the Kuopio Ischaemic heart disease risk factor study. Am J Clin Nutr. 2019;110:1416\u201323.","journal-title":"Am J Clin Nutr"},{"key":"4934_CR45","doi-asserted-by":"publisher","DOI":"10.1159\/000488483","author":"RM Vintimilla","year":"2018","unstructured":"Vintimilla RM, Large SE, Gamboa A, Rohlfing GD, O\u2019Jile JR, Hall JR, O\u2019Bryant SE, Johnson LA. The link between potassium and mild cognitive impairment in Mexican-Americans. Dement Geriatr Cogn Dis Extra. 2018. https:\/\/doi.org\/10.1159\/000488483.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"issue":"1","key":"4934_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12906-018-2167-z","volume":"68","author":"M Okuda","year":"2018","unstructured":"Okuda M, Fujita Y, Katsube T, Tabata H, Yoshino K, Hashimoto M, Sugimoto H. Highly water pressurized brown rice improves cognitive dysfunction in senescence-accelerated mouse prone 8 and reduces amyloid beta in the brain. BMC Complement Altern Med. 2018;68(1):110.","journal-title":"BMC Complement Altern Med"},{"key":"4934_CR47","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2010-1404","author":"MH Eskelinen","year":"2010","unstructured":"Eskelinen MH, Kivipelto M. Caffeine as a protective factor in dementia and Alzheimer\u2019s disease. J Alzheimers Dis. 2010. https:\/\/doi.org\/10.3233\/JAD-2010-1404.","journal-title":"J Alzheimers Dis"},{"key":"4934_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2019.00186","author":"NR Smalheiser","year":"2019","unstructured":"Smalheiser NR. Ketamine: a neglected therapy for Alzheimer disease. Front Aging Neurosci. 2019. https:\/\/doi.org\/10.3389\/fnagi.2019.00186.","journal-title":"Front Aging Neurosci"},{"key":"4934_CR49","doi-asserted-by":"crossref","unstructured":"Hara Y, McKeehan N, Dacks PA, Fillit HM. Evaluation of the neuroprotective potential of n-acetylcysteine for prevention and treatment of cognitive aging and dementia. J Prev Alzheimers Dis. (2017)","DOI":"10.14283\/jpad.2017.22"},{"issue":"23","key":"4934_CR50","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1093\/bioinformatics\/bts591","volume":"28","author":"H Kilicoglu","year":"2012","unstructured":"Kilicoglu H, Shin D, Fiszman M, Rosemblat G, Rindflesch T. Semmeddb: a pubmed-scale repository of biomedical semantic predications. Bioinformatics. 2012;28(23):3158\u201360.","journal-title":"Bioinformatics"},{"key":"4934_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-020-3517-7","volume":"21","author":"H Kilicoglu","year":"2020","unstructured":"Kilicoglu H, Rosemblat G, Fiszman M, Shin D. Broad-coverage biomedical relation extraction with SemRep. BMC Bioinform. 2020;21:1\u201328.","journal-title":"BMC Bioinform"},{"key":"4934_CR52","unstructured":"McInnes BT. Extending the log-likelihood measure to improve collocation identification. Master\u2019s thesis, Univerity of Minnesota, Minneapolis (2004)"},{"key":"4934_CR53","doi-asserted-by":"crossref","unstructured":"Lin Y, Liu Z, Sun M, Liu Y, Zhu X. Learning entity and relation embeddings for knowledge graph completion. In: Proceedings of the Twenty-Ninth AAAI conference on artificial intelligence, AAAI\u201915, AAAI Press, Austin, Texas, 2015; pp. 2181\u20132187.","DOI":"10.1609\/aaai.v29i1.9491"},{"key":"4934_CR54","doi-asserted-by":"crossref","unstructured":"Zheng D, Song X, Ma C, Tan Z, Ye Z, Dong J, Xiong H, Zhang Z, Karypis G. Dgl-ke: Training knowledge graph embeddings at scale. In: Proceedings of the 43rd international ACM SIGIR conference on research and development in information retrieval. SIGIR \u201920, Association for computing machinery, New York, NY, USA, 2020; pp. 739\u2013748.","DOI":"10.1145\/3397271.3401172"},{"key":"4934_CR55","unstructured":"Bordes A, Usunier N, Garcia-Duran A, Weston J, Yakhnenko O. Translating embeddings for modeling multi-relational data 2013; 26"},{"key":"4934_CR56","unstructured":"Yang B, Yih W, X H, Gao J, Deng L. Embedding entities and relations for learning and inference in knowledge bases (2015). arXiv:1412.6575"},{"key":"4934_CR57","unstructured":"Trouillon T, Welbl J, Riedel S, Gaussier E, Bouchard G. Complex embeddings for simple link prediction (2016). arXiv:1606.06357"},{"key":"4934_CR58","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jbi.2017.08.011","volume":"74","author":"S Henry","year":"2017","unstructured":"Henry S, McInnes BT. Literature based discovery: models, methods, and trends. J Biomed Inf. 2017;74:20\u201332. https:\/\/doi.org\/10.1016\/j.jbi.2017.08.011.","journal-title":"J Biomed Inf"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12859-022-04934-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-022-04934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T09:16:08Z","timestamp":1664529368000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-022-04934-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,30]]},"references-count":58,"journal-issue":{"issue":"S6","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["4934"],"URL":"https:\/\/doi.org\/10.1186\/s12859-022-04934-1","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,30]]},"assertion":[{"value":"14 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"407"}}